Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: Biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries

Dana Ferraris, Rica Pargas Ficco, David Dain, Mark Ginski, Susan Lautar, Kathy Lee-Wisdom, Shi Liang, Qian Lin, May X C Lu, Lisa Morgan, Bert Thomas, Lawrence R. Williams, Jie Zhang, Yinong Zhou, Vincent J. Kalish

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: Biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science